|
|
|
 |
| Location: Home -
Products - Active Pharma Ingredients(API) - Vitamin D series compounds
|
2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3
| Catalogue No. : |
C13608 |
| Product Name: |
2-(3-Hydroxypropoxy)-1,25-dihydroxyvitamin D3 |
| Synonym: |
ED-71;Eldecalcitol;2.beta.-(3-Hydroxypropoxy)-1.alpha |
| CAS No. : |
104121-92-8 |
| Structure : |
|
| Molecular Formula: |
C30H50O5 |
| Molecular Weight: |
490.72 |
| Solubility: |
DMSO |
| Purity: |
>98% |
| Usage: |
Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is an analog of 1,25-dihydroxyvitamin D3 that improves bone mineral density. Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is more efficacious than alfacalcidol in preventing vertebral and wrist fractures in osteoporotic patients with vitamin D sufficiency, with a safety profile similar to alfacalcidol. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
